We are delighted to report that Regorafenib has been recommended for use within NHS Wales for GIST
Please see the AWMSG Website.
This means that within three months of Ministerial approval (issued July 2015), regorafenib will be routinely available in the NHS across Wales.
A fantastic outcome for GIST patients in Wales!